Активни:
Намерени 4,781 изпитвания
Стр. 194 от 240
Not yet recruiting
Phase 1/2
Safety and Efficacy of BMS-986504 in Unresectable Malignant Peripheral Nerve Sheath Tumor
Malignant Peripheral Nerve Sheath Tumors
MPNST
Начало: 01.04.2026
Край: 01.07.2028
Възраст: от 12 г.
Not yet recruiting
Phase 1
A Phase I Study of HRS-5765 in Healthy Participants
Heart Failure
Начало: 01.04.2026
Край: 01.01.2027
Възраст: 18–65 г.
Not yet recruiting
Phase 3
Biologic Augmentation of TMJ Arthroscopy Using BMAC
TMJ - Oral &Maxillofacial Surgery
Oral and Maxillofacial Conditions
TMJ Pain
TMJ Arthralgia
Начало: 01.04.2026
Край: 01.06.2028
Възраст: 18–75 г.
Not yet recruiting
Kinematic vs Mechanical Alignment in High Tibial Osteotomy
Osteo Arthritis of the Knee
Genu Varum
Начало: 01.04.2026
Край: 01.10.2029
Not yet recruiting
Protecting Against Lenacapavir Misinformation With Young Women in Gauteng, South Africa ( PROTECT-L)
Misinformation
Lenacapavir
Начало: 01.04.2026
Край: 01.04.2029
Възраст: 18–29 г.
Not yet recruiting
Polycystic Ovary Syndrome in Type 1 Diabetes
Type 1 Diabetes Mellitus
Polycystic Ovary Syndrome (PCOS)
Начало: 01.04.2026
Край: 31.12.2028
Възраст: 18–45 г.
Not yet recruiting
Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology
Small Cell Lung Cancer
Head and Neck Cancer
Malignant Pleural Mesothelioma
Начало: 01.04.2026
Край: 01.04.2029
Възраст: от 18 г.
Not yet recruiting
Clinical Characterization of Patients With Primary Biliary Cirrhosis Treated With Seladelpar in the Real-life Setting
Primary Bilary Cirrhosis (PBC)
Начало: 01.04.2026
Край: 01.10.2028
Възраст: от 18 г.
Not yet recruiting
Phase 1/2
Safety and Preliminary Efficacy of CTX112 in Adult Participants With Relapsed/Refractory Hematologic Autoimmune Disease
Warm Autoimmune Hemolytic Anemia (WAIHA)
ITP - Immune Thrombocytopenia
Warm Autoimmune Hemolytic Anemia
Immune Thrombocytopenic Purpura
Начало: 01.04.2026
Край: 01.12.2033
Възраст: от 18 г.
Not yet recruiting
Proton vs Photon IMRT Toxicity in Breast Cancer
Breast Cancer
Начало: 01.04.2026
Край: 01.12.2027
Възраст: от 18 г.
Not yet recruiting
Phase 2
PSMA-High: EBRT/ PSMA617/ ADT vs. EBRT/ ADT
High-Risk Localized Prostate Cancer
Начало: 01.04.2026
Край: 01.04.2033
Възраст: от 18 г.
Not yet recruiting
Preliminary Efficacy of the AdoptMindful2Care@Web: A Web-Based Mindful Parenting Post-Adoption Intervention for Adoptive Parents
Parenting Stress
Positive Mental Health
Начало: 01.04.2026
Край: 01.08.2028
Възраст: 18–99 г.
Not yet recruiting
Effects of Biopsychosocial Models Based on Pain or Functionality in the Treatment of Chronic Musculoskeletal Pain
Chronic Pain
Начало: 01.04.2026
Край: 01.12.2026
Възраст: от 18 г.
Not yet recruiting
Peer-led Service Delivery Model for Pregnant and Lactating Adolescent Girls and Young Women in Zimbabwe
HIV Prevention
Contraceptive Usage
Adherence, Medication
Начало: 01.04.2026
Край: 01.06.2027
Възраст: 15–24 г.
Not yet recruiting
A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
Prostate Cancer
Hot Flashes
Начало: 01.04.2026
Край: 01.05.2027
Възраст: от 18 г.
Not yet recruiting
Early Phase 1
Predictors & Mechanisms of Adolescent PTSD
Posttraumatic Stress Disorder (PTSD)
Trauma Exposure
Начало: 01.04.2026
Край: 01.03.2031
Възраст: 14–18 г.
Not yet recruiting
Auricular Laser Acupuncture for Improving Sleep in Breast Cancer Patients
Breast Cancer Females
Insomnia
Начало: 01.04.2026
Край: 31.07.2027
Възраст: 18–75 г.
Not yet recruiting
Digital Lifestyle Intervention for Mental Health Among Migrants: Randomized Controlled Trial
Mental Health Disorder
Depression
Anxiety
Psychological Distress
Начало: 01.04.2026
Край: 01.10.2028
Възраст: от 18 г.
Not yet recruiting
Body Composition Outcomes in MS Patients
Obesity
Начало: 01.04.2026
Край: 31.03.2027
Възраст: от 18 г.
Not yet recruiting
Phase 2
Double-T - Improving Outcomes in High-risk 2nd Line Relapsed/Refractory Large B-Cell Lymphoma Patients Eligible for CAR-T-cell Therapy With a Glofitamab-based Induction and Consolidation Concept
Relapsed /Refractory DLBCL
Начало: 01.04.2026
Край: 01.04.2030
Възраст: 18–80 г.